NEUROVENTURES
NeuroVentures is a venture capital firm dedicated to investing in companies focused on the discovery, development and marketing of new drugs, medical devices and other therapeutics and technologies to treat central nervous system disorders.
NEUROVENTURES
Industry:
Impact Investing Trading Platform Venture Capital
Founded:
2000-01-01
Status:
Active
Contact:
+1 434 297 1000
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta Google Font API Content Delivery Network Organization Schema Typekit LocalBusiness Schema Squarespace
Similar Organizations
Batshit Crazy Ventures
Batshit Crazy Ventures is an early stage venture capital firm dedicated to working with companies that are pre-revenue and pre-seed.
Quaker BioVentures
Quaker BioVentures is a venture capital firm investing in life science companies. The firm leads investments across the spectrum of the
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2010-09-30 | NeurAxon | NeuroVentures investment in Debt Financing - NeurAxon | 14 M USD |
| 2008-03-01 | BrainCells | NeuroVentures investment in Series B - BrainCells | 30 M USD |
| 2007-08-20 | NeurAxon | NeuroVentures investment in Series B - NeurAxon | 32 M USD |
| 2006-08-17 | Acumen Pharmaceuticals | NeuroVentures investment in Venture Round - Acumen Pharmaceuticals | 1.5 M USD |
| 2005-07-15 | BrainCells | NeuroVentures investment in Series A - BrainCells | 17.7 M USD |
| 2004-07-27 | NeurAxon | NeuroVentures investment in Series A - NeurAxon | 2.5 M CAD |
| 2004-02-10 | Kadmus Pharmaceuticals | NeuroVentures investment in Series A - Kadmus Pharmaceuticals | 15.3 M USD |
| 2003-11-17 | Saegis Pharmaceuticals | NeuroVentures investment in Series B - Saegis Pharmaceuticals | 30 M USD |
| 2003-07-09 | Cyberkinetics | NeuroVentures investment in Series A - Cyberkinetics | 9.3 M USD |
| 2002-07-15 | Scion Pharmaceuticals | NeuroVentures investment in Series B - Scion Pharmaceuticals | 17.5 M USD |
More informations about "NeuroVentures"
NeuroVentures
NeuroVentures is a specialty venture capital firm dedicated to investing in companies focused on the discovery, development and marketing of new drugs, medical devices and other …See details»
NeuroVentures - Crunchbase Investor Profile & Investments
NeuroVentures is a venture capital firm dedicated to investing in companies focused on the discovery, development and marketing of new drugs, medical devices and other therapeutics …See details»
NeuroVentures - Welcome to Bio-X
NeuroVentures focuses on dramatically stimulating and accelerating interdisciplinary research to answer some of the most challenging questions concerning the body’s most complex organ, …See details»
Neuroventures Company Profile | Management and Employees …
NeuroVentures is a specialty venture capital firm dedicated to investing in companies focused on the discovery, development and marketing of new drugs, medical devices and other …See details»
NeuroVentures - Investments, Portfolio & Company Exits
Aug 20, 2020 · NeuroVentures 's most notable exits include Acumen Pharmaceuticals, Proxima Therapeutics, and Saegis Pharmaceuticals. Which industries has this organization had the …See details»
Ventures | Stanford Bio-X
NeuroVentures Bio-X leadership recognized that Stanford has the talent base, an institutional culture of teamwork, invention, and entrepreneurialism, and, in short, is the right place to lead …See details»
NeuroVentures Capital investment portfolio - PitchBook
Information on investments, active portfolio, exits, fund performance, dry powder, and co-investors for NeuroVentures Capital. Use the PitchBook Platform to explore the full profile.See details»
People - NeuroVentures
Dan O’Connell has over 15 years of early-stage venture creation an investment experience, with a particular emphasis on working with start-up life sciences companies and their scientific and …See details»
Bio-X Stanford University
As Bio-X matures, its leaders expect its endeavors to grow in scope and ambition, necessitating a deeper commitment of seed funding. Bold new undertakings-called Bio-X Ventures-will rely on …See details»
Melanie Leitner | Carney Institute for Brain Science - Brown …
Melanie Leitner currently serves as the Chief Scientific Officer for the ALS Investment Fund (a life sciences VC) and is the founder of Accelerating NeuroVentures, LLC, a solo consulting …See details»
Daniel O’Connell | Acumen Pharmaceuticals
Daniel O’Connell has over 20 years of venture creation, venture investment and start-up operations experience with a focus on Neurosciences companies. He has served as President …See details»
| Neuro Ventures
We have resources and expetise in healthcare and interventional device market sectors. NeuroVentures is uniquely positioned to offer new technology advice on product introduction …See details»
NeuroVentures Fund: Performance - PitchBook
NeuroVentures Fund was a venture capital fund managed by NeuroVentures Capital. The fund was located in Charlottesville, Virginia and invested in the United States and Canada. The …See details»
Pridopidine’s Impact on ALS, Assessing Results From HEALEY ALS …
May 23, 2023 · The consultant and founder of Accelerating NeuroVentures talked about the pridopidine arm from the HEALEY ALS Platform trial, which showed significant benefits in …See details»
NeuroVentures - Tech Stack, Apps, Patents & Trademarks
NeuroVentures uses 5 technology products and services including HTML5 , Google Fonts , and Adobe Fonts, according to G2 Stack. NeuroVentures is actively using the technology …See details»
Bio-X NeuroVentures program aims to unlock the secrets of the …
NeuroVentures will promote collaborations that transcend the field of neuroscience, with the ultimate goal of unlocking secrets of the brain and intelligence. He envisions facilitating …See details»
Understanding and Preventing Neuropathic Pain | Welcome to Bio-X
In this proposal, we will use a new technique in neuroscience that allows us to control the activity of these nerve fibers using light and determine if changes in nerve activity produces symptoms …See details»
NeuroVentures
We are an AI-powered software venture builder based in Taiwan - we ideate, design, build and operate next-generation products enhanced by AI.See details»
Neuron23â„¢ Closes $113.5 Million Series A and B Financing led by ...
Dec 16, 2020 · SOUTH SAN FRANCISCO, Calif., Dec. 16, 2020 /PRNewswire/ -- Neuron23â„¢ Inc., an early stage biotechnology company focused on developing precision medicines for …See details»
Robert Walters to occupy the world’s first office based on …
For this project, Hoogerwerf partnered with Neuroventures, a specialist in neurological and behavioural science. This scientific research was conducted with Neurensics, the founder of …See details»